- Home
- PSNYW vs GOSS Comparison
PSNYW vs GOSS Comparison
Compare PSNYW & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNYW
- GOSS
- Stock Information
- Founded
- PSNYW 2017
- GOSS 2015
- Country
- PSNYW Sweden
- GOSS United States
- Employees
- PSNYW 2547
- GOSS N/A
- Industry
- PSNYW Auto Manufacturing
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- PSNYW Consumer Discretionary
- GOSS Health Care
- Exchange
- PSNYW Nasdaq
- GOSS Nasdaq
- Market Cap
- PSNYW 625.2M
- GOSS 347.8M
- IPO Year
- PSNYW N/A
- GOSS 2019
- Fundamental
- Price
- PSNYW $0.30
- GOSS $2.47
- Analyst Decision
- PSNYW
- GOSS Strong Buy
- Analyst Count
- PSNYW 0
- GOSS 4
- Target Price
- PSNYW N/A
- GOSS $8.50
- AVG Volume (30 Days)
- PSNYW 43.4K
- GOSS 3.1M
- Earning Date
- PSNYW 03-06-2025
- GOSS 08-05-2025
- Dividend Yield
- PSNYW N/A
- GOSS N/A
- EPS Growth
- PSNYW N/A
- GOSS N/A
- EPS
- PSNYW N/A
- GOSS N/A
- Revenue
- PSNYW $2,034,261,000.00
- GOSS $40,237,000.00
- Revenue This Year
- PSNYW N/A
- GOSS N/A
- Revenue Next Year
- PSNYW $79.49
- GOSS $30.65
- P/E Ratio
- PSNYW N/A
- GOSS N/A
- Revenue Growth
- PSNYW N/A
- GOSS N/A
- 52 Week Low
- PSNYW $0.09
- GOSS $0.66
- 52 Week High
- PSNYW $0.61
- GOSS $2.65
- Technical
- Relative Strength Index (RSI)
- PSNYW 56.04
- GOSS 68.08
- Support Level
- PSNYW $0.16
- GOSS $2.38
- Resistance Level
- PSNYW $0.80
- GOSS $2.65
- Average True Range (ATR)
- PSNYW 0.06
- GOSS 0.15
- MACD
- PSNYW 0.02
- GOSS 0.03
- Stochastic Oscillator
- PSNYW 15.62
- GOSS 76.67
About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.